carbetocin   Click here for help

GtoPdb Ligand ID: 11169

Synonyms: Pabal®
Approved drug
carbetocin is an approved drug (UK (2007))
Comment: Carbetocin is an oxytocin analogue. Like oxytocin it acts as an oxytocic, antihemorrhagic and uterotonic drug. Activating this pathway has already been shown to reduce food intake and body weight in both animal models and human clinical studies, and as a result oxytocin (plus analogues and non-peptide mimetics) is being evaluated for anti-obesity potential [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C
Isomeric SMILES CC[C@@H]([C@@H]1NC(=O)[C@@H](NC(=O)CCCSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H](NC1=O)CCC(=O)N)CC(=O)N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N)CC(C)C)Cc1ccc(cc1)OC)C
InChI InChI=1S/C45H69N11O12S/c1-6-25(4)38-44(66)51-28(15-16-34(46)57)40(62)52-31(21-35(47)58)41(63)54-32(23-69-18-8-10-37(60)50-30(42(64)55-38)20-26-11-13-27(68-5)14-12-26)45(67)56-17-7-9-33(56)43(65)53-29(19-24(2)3)39(61)49-22-36(48)59/h11-14,24-25,28-33,38H,6-10,15-23H2,1-5H3,(H2,46,57)(H2,47,58)(H2,48,59)(H,49,61)(H,50,60)(H,51,66)(H,52,62)(H,53,65)(H,54,63)(H,55,64)/t25-,28-,29-,30-,31-,32-,33-,38-/m0/s1
InChI Key NSTRIRCPWQHTIA-DTRKZRJBSA-N
No information available.
Summary of Clinical Use Click here for help
Carbetocin is used to prevent postpartum haemorrhage due to uterine atony.
An intranasally delivered formulation of carbetocin (LV-101) is being developed by Levo Therapeutics as a treatment for Prader-Willi syndrome. It is intended to reduce the feeling extreme hunger that leads to hyphagia in these patients.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03649477 Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome Phase 3 Interventional Levo Therapeutics, Inc.
NCT01968187 Treatment of Hyperphagia Behavioral Symptoms in Children and Adults Diagnosed With Prader-Willi Syndrome Phase 2 Interventional Ferring Pharmaceuticals
External links Click here for help